Member Info for crumbs

plus you can inject all sorts into a tumour and cause it to shrink by stimulating a local response... getting metastasis is the tricky part... SCIB1 shrank lung metastasis .... which considering in its best setting it is really an early stage i.e either before or at the time of resection therapy ...

It might sound like SCIB1 (DNA plasmid -electroporation) but it's nothing like it ,oncosec has been covered here in the past and intratumoral means injecting directly into a tumour with an electro device... nice... anyways well done them on their progress can't knock them there

It's not outlandish at all Tesla have form https://www.bbc.co.uk/news/business-56288781 and they have a working relationship with Piedmont of course it would not happen until IRR get full value and know the true extent to the Lithium asset... unless of course an offer that cannot be refused arrived :) anyways a great position to be in and I reckon this is going to be an exciting place to be for the coming months and years... in it for freebie golden tickets.... can't understand sellers but guess that makes a market and they must have a need not to want those golden tickets and the lithium fun to come :)

Ahh ok

Interesting too about what could be coming from the gold spin out... and that there could be enough assets for multiple companies to be formed lol... anyways I feel he is right about the Americans will wake up to this and pile in.... could even tesla themselves buy IRRs Ewoyyas 50%

Correct about what? .....

I don't see any reason the posts on this thread will be removed ... it was a lame dig by kash that has been dealt with by posters here....

Up to now, CEPI hasn't spent a dime of the $200 million they have for their recent call for more broadly targeting vaxs....
Also, they have a rather large diverse and growing portfolio of vaxs... Clover being just one... all a bit of a none issue really I'm certain CEPI are well aware of Covidity and it about to trial in SA....

'The platform technology'
It is classed as a platform maybe gives weight to that being the 'zachari theraputics' big dark room in the scncell B&B theory :)

Till we know we are in the dark but once again I would not be surprised if this tech is brought in house .... and again all mRNA players you know the most talked about in the world will be looking at Covidity trial to see how this performs because it could offer a viable alternative to their reliance on lipid delivery..... another little bit of massive potential from the scancell mix

https://mcusercontent.com/d9ebd7c1aa0f3dbc5fab42eca/files/0ef037c2-95db-7761-090f-07abca5f73fb/IronRidge_Resources_Update_Note_V5_.pdf

For your perusal

Sounds like Ironridges 50% is open to offers :)))

https://www.youtube.com/watch?v=n4dXpDxgUBo

It sounds like Piedmonts plans for Ewoyya are for it to be as big a part of their Lithium business as their N American assets... market will wake up to all this ... meantime... load up :)

https://www.youtube.com/watch?v=JzTuHV2t6SA

A nice fly over the orange glow of the producing a profit for UJO wrestle at 1.00 to compare the orangeness of the glow...
https://twitter.com/EgdonResources/status/1394533710075027457

A zoom and historic pics to compare is all you need

Rubey on the RBD BB has pointed out the orange glow inside the circular flare stack..

Yes brilliant, especially this:

'If you can 'go hard and go fast' on a cancer, you don't give it the chance to mutate. As such, many treatments aim to do just that. They aim to remove 100% of the tumour through chemo, radio or immunotherapy to prevent the chance of escape and relapse. When a patient does relapse, this tumour tends to be different from the original one and so new therapies are needed.'

That is so it!... And why finding multiple valid cancer-specific targets especially if they are universal and not just patient-specific is so crucial and has proven so hard but moditope may just offer an answer there .... we know if you go after just one target and cancer mutates to no longer express that target then your therapy fails.....Hope to hear modi1 trial news soon.

Yeah... I do think it will be exciting! ... there is so much potential that could be RNS'd the science we know never ever sleeps here... it really seems that now more is brewing as in 'The Redmile plan' and that we could well be in for some actual valuing of the IP that has been built up over years....We know that lesser IP is IPO'd on NASDAQ for billions... Although we all expected trial news I don't think any of us thought South Africa... always surprises we have to have faith that the BOD will pull it all off.... but if that Covidity package works and works as well as it could there is no way we are staying with an mcap below a billion IMHO...I'd really like to know whats going on with modi 1 though.... we are very much in the dark

moon, seeing as we have no idea what Zacari is all about,who knows lol.... Just to my thinking if you get a trialled AvidiMab proving itself via trial and indeed the whole Covidity package then there is no need for any spinning it off...the Glycan Mabs probably are most likely (as per Berms theory) ...I came up with a TCR one involving what Lindy is coming up with in the Continuum collab possibly using moditope.... there are others ... possible novel delivery that has been developed for Covidity for example... but till we don't we don't and though I think its not a picking up his ball and leaving issue I agree with Evans its not good form to keep us in the dark about such a potentially game-changing move .....I'm in a Lithium miner they got a new broker and will spin off their gold assets and they RNS'd it all... scancell nah... keep em guessing!

I can't see AvidiMab being 'hived off' seeing as it is about to be trialled (validated) ... and on success becomes a potential multi £billion licensing product all of scancells own.... the glycan MaBs maybe....